Sui price tests support near $3.10 as traders eye recovery amid rising institutional demand
Sui price is testing support at $3.10 as rising trading volume and new partnerships hint at long-term strength.
- SUI trades at $3.13, down 18% weekly, with $1.66B spot volume up 46% in 24h.
- Futures volume rises 23% to $7.48B while open interest falls 4.4%, showing cautious positioning.
- New deals with t’order, CUDIS Wellness, and Google AI highlight institutional and real-world adoption.
Sui is trading at $3.13 at press time, down 3.5% in the past 24 hours, as the token approaches key support levels. Over the past week, it has dropped 18%, while in the past 30 days, it is still down 10%.
Daily trading activity shows a surge in market interest, with $1.66 billion in spot volume recorded in the last 24 hours, a 45.9% jump compared to the previous day. On the derivatives side, CoinGlass data shows that Sui’s ( SUI ) open interest fell 4.4% to $1.69 billion, while futures volume rose 23% to $7.48 billion.
This combination implies that although traders are engaging more actively, many are closing out positions rather than opening new ones.
New partnerships drive long-term use cases
Despite the near-term pullback, Sui continues to expand its ecosystem with major partnerships that strengthen its institutional and real-world presence.
On Sept. 24, Sui announced a partnership with t’order, the leading table-ordering platform in South Korea, T’order processes $4.3 billion annually and serves 35 million users. Using Sui’s sub-0.5-second transaction speeds and Walrus storage for safe loyalty data, the partnership integrates a KRW-pegged stablecoin across 300,000 point-of-sale devices.
A day later, Sui partnered with CUDIS Wellness to bring AI-powered smart rings and health data management onchain. Through Walrus and SEAL, users will own and monetize encrypted biometric data, aligning Sui with the growing wellness sector.
Sui and Google AI also partnered to introduce the Agentic Payments Protocol earlier this month. This system opens up new use cases in DeFi, IoT, and enterprise automation by enabling AI agents to make payments on their own.
Sui price technical analysis
On the daily chart, SUI is trading close to the lower Bollinger band at $3.13, indicating oversold conditions. The relative strength index at 38 is near the oversold zone, while the Stochastic RSI and Williams %R both indicate possible buy conditions.
Sui daily chart. Credit: crypto.news
All of the major SMAs and EMAs, from the 10-day ($3.38) to the 200-day ($3.20), flash sell signals, a bearish sign. Momentum and MACD indicators also lean bearish, showing the trend is still weak.
In the short term, holding above $3.10 support is critical. The $2.90–$3.00 range might be the next target if there is a breakdown. On the upside, the first indication of a potential rebound would be the recovery of the 20-day SMA around $3.46.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?
The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.
The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives
For months, investors have been worried about a series of risks behind the AI (artificial intelligence) capital expenditure "money tree." This week, the market finally pressed the panic selling button.
Crypto prices
More
